Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 120,192,308
- Total 13F shares
- 47,601,655
- Share change
- +3,763,294
- Total reported value
- $157,593,347
- Put/Call ratio
- 317%
- Reported price per share
- $3.31
- Number of holders
- 115
- Value change
- +$12,692,456
- Number of buys
- 66
- Number of sells
- 45
Security identity
Holder snapshot
Report period
Q2 2025
Institutions
115
Top holders
10
AQST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03843E104
Recent filing periods:
Ownership snapshot
Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Douglas K. Bratton
13D/G signal
Douglas K. Bratton
Evidence rows
50
Latest as of
31 Mar 2025
13D/G
3/4/5
13F
Lead comparable stake: 11%
13D/G row: Douglas K. Bratton
Showing first 8 of 50 holder rows.
Open remaining rows
Rank 1 holder
Douglas K. Bratton
13D/G
3/4/5
- Ownership
- 11%
- Position
- $28.72M
Rank 2 holder
Venrock Healthcare Capital Partners III, L.P.
13D/G
- Ownership
- 2.9%
- Position
- $7.49M
Rank 3 holder
Bratton Capital Management, L.P.
13F
- Ownership
- 8.2%
- Position
- $28.45M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Douglas K. Bratton |
13D/G
3/4/5
BRATTON DOUGLAS K · 10%+ Owner
|
11%
|
$28,720,687
10,077,434 shares
|
$0 | 31 Dec 2024 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
2.9%
|
$7,494,890
2,629,786 shares
|
$0 | 31 Dec 2024 |
| Bratton Capital Management, L.P. |
13F
Company
|
8.2%
|
$28,451,778
9,810,958 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
4.9%
|
$17,213,686
5,935,754 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
3.4%
|
$11,813,318
4,073,558 shares
|
— | 31 Mar 2025 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
3.1%
|
$10,808,903
3,727,208 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.4%
|
$4,933,107
1,700,706 shares
|
— | 31 Mar 2025 |
| MORGAN STANLEY |
13F
Company
|
1.3%
|
$4,429,139
1,527,289 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
115
Shares
47,601,655
Rows loaded
116
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
120
Q2 2025 holders
115
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend